Chemical Structure (Losartan Pot 50mg 1)
Losartan Potassium
Product Images NDC 53217-337
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53217-337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Losartan Pot 50mg 2)
This is a comparison between two medications, Atenolol and Losartan Potassium, in terms of their effectiveness in reducing the primary endpoint in patients. An adjusted risk reduction of 13% with a p-value of 0.021 was observed. The study was conducted for a duration of 66 months with data collected at specific intervals ranging from 0 to 66 months.*
Figure 2 (Losartan Pot 50mg 3)
This is a comparison of two medications, Atenolol and Losartan Potassium, with an adjusted risk reduction of 25%. The percentages of patients with fatal/non-fatal stroke are listed over a span of 66 months.*
Figure 3 (Losartan Pot 50mg 4)
The text describes a table (Figure 3) with results of a study comparing losartan potassium and atenolol in relation to stroke in different demographic subgroups. The primary endpoint was composite stroke (fatal/non-fatal), and the table shows the number of events, rate (%), and hazard ratio (95% CI) for each subgroup. The subgroups analyzed were: age (<65 years and >65 years), gender (male and female), race (white, black and other), ISH (yes/no), Diabetes (yes/no), and history of CVD (yes/no). The table also includes symbols proportional to the sample size, and a note explaining that the analysis was adjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypertrophy.*
Figure 4 (Losartan Pot 50mg 5)
53217-0337_losartan-pot_50mg (Losartan Pot 50mg 6)
This is a description of a medication called Losartan Potassium, USP, which comes in a 50mg dosage and a package of 30 tablets. The tablets are white, round, and film-coated, with the marking "W 5" on one side and a score of "11" on the other. It is a generic version of the medication Cozaar. The medication was packaged by NidareX and manufactured by Zhejiang Huahai Pharmaceutical Co. in China. There are several NDC numbers and lot numbers listed. There is also an RX number and recommended dosage information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
